Bakul Patel, Senior Policy Advisor, FDA’s Center for Devices and Radiological Health

The growth of healthcare apps is proving a challenge to the Food and Drug Administration. In a new report it says it’s not so worried about the ones that help doctors with billing or scheduling or even those that they use to care for patients, such as e-prescription software. But there’s a third category of high-risk devices that regulators are watching closely. Bakul Patel, the senior Policy advisor for the FDA’s Center for Devices and Radiological Health, tells Tom Temin and Emily Kopp on Federal Drive that it’s about function, not form.